OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 60 filers reported holding OVID THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $256,911 | -1.7% | 84,233 | +3.8% | 0.00% | 0.0% |
Q4 2023 | $261,384 | -16.1% | 81,175 | +0.0% | 0.00% | -50.0% |
Q3 2023 | $311,704 | +37.2% | 81,173 | +17.2% | 0.00% | +100.0% |
Q2 2023 | $227,130 | +185.3% | 69,247 | +124.4% | 0.00% | – |
Q1 2023 | $79,614 | +7.2% | 30,858 | -22.7% | 0.00% | – |
Q4 2022 | $74,251 | -4.8% | 39,920 | -6.3% | 0.00% | -100.0% |
Q3 2022 | $78,000 | -1.3% | 42,585 | +15.9% | 0.00% | – |
Q2 2022 | $79,000 | -71.1% | 36,748 | -57.7% | 0.00% | -100.0% |
Q1 2022 | $273,000 | -28.9% | 86,888 | -27.3% | 0.00% | -50.0% |
Q4 2021 | $384,000 | -42.8% | 119,573 | -40.1% | 0.00% | -50.0% |
Q3 2021 | $671,000 | -33.4% | 199,573 | -22.5% | 0.00% | -20.0% |
Q2 2021 | $1,007,000 | -0.5% | 257,564 | +2.3% | 0.01% | -16.7% |
Q1 2021 | $1,012,000 | +88.8% | 251,764 | +8.5% | 0.01% | +100.0% |
Q4 2020 | $536,000 | -37.7% | 232,059 | +54.7% | 0.00% | -50.0% |
Q3 2020 | $861,000 | -38.5% | 149,989 | -21.0% | 0.01% | -40.0% |
Q2 2020 | $1,400,000 | +196.0% | 189,967 | +19.8% | 0.01% | +150.0% |
Q1 2020 | $473,000 | – | 158,587 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 1,490,534 | $2,772 | 13.66% |
Madison Avenue Partners, LP | 2,721,051 | $5,061,155 | 0.90% |
Rubric Capital Management LP | 6,828,065 | $12,700,201 | 0.55% |
BVF INC/IL | 6,851,051 | $12,742,955 | 0.54% |
CHI Advisors LLC | 864,822 | $1,608,569 | 0.43% |
EcoR1 Capital, LLC | 6,117,400 | $11,378,364 | 0.35% |
Artal Group S.A. | 2,500,000 | $4,650 | 0.26% |
Tejara Capital Ltd | 107,491 | $199,933 | 0.12% |
Oasis Management Co Ltd. | 270,000 | $502,200 | 0.10% |
DCF Advisers, LLC | 70,264 | $130,691 | 0.09% |